亚辉龙与美年健康达成战略合作 构筑健康管理新生态

Core Insights - The strategic partnership between Meinian Health and Aihuilong aims to integrate advanced in vitro diagnostic technology with a vast health examination network and AI health management platform to enhance disease screening efficiency and preventive medicine levels [1][2] Group 1: Partnership Objectives - The collaboration focuses on building a comprehensive health management service system that spans prevention, diagnosis, treatment, and management, aligning with national health management guidelines [2][3] - Meinian Health's Chairman emphasized that this partnership is a significant milestone in deepening health service capabilities and enhancing professional barriers [2] Group 2: Specific Areas of Focus - Aihuilong will assist Meinian Health in customizing autoimmune disease screening packages tailored to different examination populations, enabling early identification and risk warning for high-risk individuals [3] - The partnership will establish a comprehensive management system for high-risk cardiovascular patients, integrating prevention, diagnosis, treatment, and management into a closed-loop healthcare pathway [3] Group 3: Future Vision - The collaboration aims to create a continuously evolving and collaboratively innovative health management ecosystem that provides proactive health management services across the entire life cycle [4] - This initiative supports the national chronic disease prevention strategy and contributes to the broader "Healthy China" vision through industry innovation [4]